MAIA Biotechnology Inc. (MAIA)
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026
Fusemachines Expands Access to Agentic AI for Talent Acquisition Through Broad ATS Connectivity
Nightfood Holdings Inc. (OTCQB: NGTF) Builds AI-Driven Automation Tools for Hospitality, Pharmaceutical, Lab and Industrial Spaces
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
Vonage Brings Agentic Communications to Millions of Developers with Vonage API Power for Kiro
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003
Stable Commits U.S. $100M to Zenzic Capitals Evergreen Credit Strategy as the Firm Continues its Institutional Expansion